Cigna Group (The) (CI) DIvidends Date & History

Key Takeaways

• The Cigna Group pays a quarterly dividend of $1.56 per share, raised from $1.51 in 2025, equating to a forward annual payout of roughly $6.24 per share.
• The stock's dividend yield sits near 2.2%, a modest but competitive level relative to several large managed-care peers.
• Cigna maintains a low payout ratio of roughly 21% to 27%, signaling ample earnings coverage and room for future increases.
• The company has raised its dividend for five consecutive years, including a 7.9% increase in 2025.
• With steady dividend growth and a conservative payout, CI appeals primarily to dividend growth and long-term investors rather than pure income seekers.

Dividend Overview

The Cigna Group, a global health services company, maintains a disciplined quarterly dividend policy. Its current quarterly payment of $1.56 per share brings the forward annual dividend to about $6.24 per share, yielding roughly 2.2% at recent prices. Dividends are paid every three months, with recent ex-dividend dates in March, June, September, and December of each year.

Cigna is best described as a dividend growth stock with a modest yield rather than a high-yield income vehicle. The company initiated a meaningful dividend ramp after its 2018 acquisition of Express Scripts and has since prioritized steady, compounding increases. While the yield may not attract investors seeking immediate income, the company's low payout ratio and consistent growth make it an appealing candidate for those focused on long-term total return and rising cash distributions.

Dividend History and Growth

Cigna's dividend has climbed at a notable pace in recent years. The quarterly payout advanced from $1.00 per share in 2021 to $1.12 in 2022, $1.23 in 2023, $1.40 in 2024, $1.51 in 2025, and $1.56 for 2026. This represents five consecutive years of increases, with the 2025 raise of about 7.9% among the larger hikes in the managed-care sector.

The pattern reflects management's confidence in the company's earnings and cash-flow generation. Cigna has paired its dividend growth with an active share-repurchase program, reinforcing a broader capital-return strategy. Although the company does not yet carry the decade-long growth streaks of some legacy dividend payers, its recent trajectory suggests a clear commitment to rewarding shareholders through rising quarterly payments.

Dividend Sustainability and Payout Ratio

Cigna's dividend appears well supported by underlying fundamentals. Its payout ratio — the share of earnings paid out as dividends — has ranged from roughly 21% to 27% in recent periods, a conservative level that leaves substantial earnings retained for reinvestment and share buybacks. On a cash basis, dividend payments consume only about 21% of free cash flow (FCF), the cash remaining after operating expenses and capital spending, further underscoring sustainability.

The company's diversified revenue base spans health insurance, pharmacy benefit management, and specialty services, providing relatively stable cash generation. While the managed-care industry faces regulatory and cost pressures, Cigna's low payout ratio gives it a wide margin of safety to maintain and grow the dividend even in a challenging earnings environment. This cushion distinguishes it from higher-yielding peers that distribute a larger share of profits.

Dividend Compared to Industry Peers

Within the managed-care and health-services sector, Cigna's yield is broadly competitive. UNH (UnitedHealth Group) recently yields around 2.3% with a substantially higher payout ratio, while ELV (Elevance Health) yields below 2%. CVS (CVS Health) offers a higher yield of roughly 3% to 4%, but its dividend has been held flat in recent years amid earnings pressure.

By contrast, Cigna combines a mid-range yield with one of the sector's fastest recent dividend growth rates and a notably low payout ratio. For investors weighing yield against growth potential and sustainability, CI sits in an attractive middle ground: it offers more income than lower-yielding peers while maintaining far greater capacity for future increases than the higher-yielding names in the group.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is also useful for identifying dividend stocks, income-focused investments, breakout candidates, and other market opportunities far more efficiently than manual screening. Investors researching names like CI can use the AI Screener to compare dividend characteristics and technical setups across the healthcare sector.

Is This Stock Attractive for Dividend Investors?

Cigna may suit dividend growth investors and long-term, total-return-oriented investors more than those seeking immediate high income. With a yield near 2.2%, it does not compete with traditional high-yield stocks, but its low payout ratio, consistent annual increases, and strong free cash flow suggest the dividend can continue compounding over time.

Conservative investors may also appreciate the company's diversified healthcare revenue streams and disciplined capital management. However, the stock is not without risks: regulatory scrutiny of the health-insurance and pharmacy-benefit industries, cost pressures, and potential earnings volatility could influence future payout decisions. Investors focused purely on current income, or those seeking a mature multi-decade dividend growth streak, may find other opportunities more aligned with their goals. As with any investment, individual financial circumstances and risk tolerance should guide decisions rather than yield alone.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations